Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member printed question first answered answering member label attachment file name file name title title
tabling member	label

Search

423173

	registered interest
	date	22/10/2015
	answering body	Department for Transport
	answering dept id	27
	answering dept short name	Transport
	answering dept sort name	Transport
	hansard heading	Great Western Main Line
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government what analysis they have conducted of the impact of having diesel and electric engines fitted to the new Hitachi Great Western Mainline trains on journey times (1) between Paddington and Cardiff, and (2) between Cardiff and Swansea.
	tabling member printed	Baroness Randerson
	uin	HL2923
	answer	answer is ministerial correction date of answer 04/11/2015 answer text <p>The Department for Transport is analysing the impact of Great Western electrification delays on the configuration of the Intercity Express Programme fleet. The analysis is looking at the timetable implications including journey times and capacity. The analysis will be informed by the recommendations made by Sir Peter Hendy. No final decisions have been made.</p> answering member printed Viscount Younger of Leckie question first answered 04/11/2015 11:35:32 answering member 4169 label Biography information for Viscount Younger of Leckie
	tabling member	4230 label Biography information for Baroness Randerson

846692

	registered interest
	date	21/02/2018
	answering body	Department for Education
	answering dept id	60
	answering dept short name	Education
	answering dept sort name	Education
	hansard heading	Overseas Students: EU Nationals
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government when they intend to clarify the fee status of EU students studying at UK universities from September 2019.
	tabling member printed	Baroness Randerson
	uin	HL5747
	answer	answer is ministerial correction date of answer 05/03/2018 answer text <p>Future arrangements for EU students starting courses after 2018/19, and who are not settled in the UK or on a pathway to settled status by the specified date, will need to be considered as part of wider discussions about the UK’s relationship with the EU.</p><p> </p><p>Applications for courses starting in 2019/20 do not open until September 2018, and we are working to ensure students applying have information well in advance of this date.</p> answering member printed Viscount Younger of Leckie question first answered 05/03/2018 12:52:46 answering member 4169 label Biography information for Viscount Younger of Leckie
	tabling member	4230 label Biography information for Baroness Randerson

598107

	registered interest
	date	10/10/2016
	answering body	HM Treasury
	answering dept id	14
	answering dept short name	Treasury
	answering dept sort name	CaTreasury
	hansard heading	M20: Large Goods Vehicles
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government whether the National Infrastructure Commission will examine the economic impact of (1) the deployment of Operation Stack in 2015, and (2) their plans for a lorry area to address problems caused by Operation Stack.
	tabling member printed	Baroness Randerson
	uin	HL2136
	answer	answer is ministerial correction date of answer 18/10/2016 answer text <p>The National Infrastructure Commission (NIC) will examine strategic transport infrastructure when it conducts its first National Infrastructure Assessment.</p><p> </p><p>The Chancellor, together with the NIC, has launched a call for ideas to give stakeholders an opportunity to contribute their ideas for issues which could form the subject of future NIC studies. This process will help us ensure the NIC is focused on the country’s most critical infrastructure challenges.</p> answering member printed Lord Young of Cookham question first answered 18/10/2016 11:47:52 answering member 57 label Biography information for Lord Young of Cookham
	tabling member	4230 label Biography information for Baroness Randerson

444872

	registered interest
	date	14/01/2016
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Hepatitis: Prisoners
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government what advice and guidance has been provided by Public Health England in relation to the commissioning and performance management of prison healthcare service for prisoners diagnosed with Hepatitis C or identified as being at risk of developing Hepatitis C.
	tabling member printed	Baroness Randerson
	uin	HL5070
	answer	answer is ministerial correction date of answer 26/01/2016 answer text <p>Public Health England (PHE), NHS England and the National Offender Manager Service (NOMS) have worked together to improve the diagnosis of blood-borne viruses (BBVs) (including Hepatitis C) among people in prison and to provide access to treatment and care for those infected through collaborative implementation of the BBV opt-out testing programme, published in the National Partnership Agreement in 2015. A copy of the Agreement is attached.</p><p>PHE has published detailed expert advice to commissioners and prison healthcare services on all aspects of implementation of BBV opt-out testing, including testing and treatment algorithms. Further, PHE has supported dissemination of guidance through a programme of training and engagement events in partnership with the voluntary sector. PHE has co-developed with NHS England and NOMS a set of performance metrics called the Health &amp; Justice Indicators of Performance (HJIPs) to provide data on the number of people tested, the number requiring treatment and those referred for treatment which supports commissioners in performance management of prison healthcare services.</p> answering member printed Lord Prior of Brampton question first answered 26/01/2016 13:09:58 answering member 127 label Biography information for Lord Prior of Brampton attachment 1 file name Partnership Agreement (HL5070 attachment).pdf title Partnership Agreement
	tabling member	4230 label Biography information for Baroness Randerson

434110

	registered interest
	date	03/12/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Prisoners: Hepatitis
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government what incentives and performance targets exist to encourage HM Prison Service to improve rates of testing for hepatitis C among prisoners.
	tabling member printed	Baroness Randerson
	uin	HL4229
	answer	answer is ministerial correction date of answer 15/12/2015 answer text <p>Improving the proactive detection, surveillance and management of infectious diseases in prisons is a shared priority for the National Offender Management Service, NHS England and Public Health England, as described in the Second National Partnership Agreement published earlier this year. A copy is attached.</p><p>Included within this work programme is implementation of the blood-borne virus (BBV) opt-out testing programme for people in prisons, which includes testing for Hepatitis C virus infection as well as Hepatitis B virus and HIV.</p><p>The ambition is to have BBV opt-out testing in all adult prisons in England by end of the financial year 2016-17.</p><p>While there are currently no financial incentives or direct performance targets, performance in this activity is measured by NHS England through the collection of data via the Health &amp; Justice Indicators of Performance. The data are used by NHS England commissioners to performance manage healthcare providers in prisons.</p> answering member printed Lord Prior of Brampton question first answered 15/12/2015 15:52:38 answering member 127 label Biography information for Lord Prior of Brampton attachment 1 file name national_partnership_agreement_commissioning-delivery-healthcare-prisons_2015.pdf title National Partnership Agreement
	tabling member	4230 label Biography information for Baroness Randerson

520593

	registered interest
	date	23/05/2016
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Civil Servants: Pay
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government why NHS England has decided to restrict hepatitis C treatment, with providers subject to a financial penalty if they do not keep within specified numbers, despite those treatments being approved as cost-effective by NICE.
	tabling member printed	Baroness Randerson
	uin	HL231
	answer	answer is ministerial correction date of answer 07/06/2016 answer text <p>The National Institute for Health and Care Excellence (NICE) specifically requires Operational Delivery Networks (ODNs) to prioritise hepatitis C patients on the basis of highest unmet clinical need, as part of a progressive rollout of treatments over the next five years.</p><p> </p><p>NHS England is funding providers to treat patients at the rate outlined in NICE’s guidance, Technology Appraisals 363, 364 and 365, apportioned to local ODNs based on local health needs. Copies of these Technology Appraisals are attached.</p> answering member printed Lord Prior of Brampton attachment 1 file name NICE TA 363.pdf title NICE Technology Appraiasal 363 2 file name NICE TA 364.pdf title NICE Technology Appraisal 364 3 file name NICE TA 365.pdf title NICE Technology Appraisal 365 question first answered 07/06/2016 14:58:53 answering member 127 label Biography information for Lord Prior of Brampton
	tabling member	4230 label Biography information for Baroness Randerson

632755

	registered interest
	date	09/11/2016
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Hepatitis
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government, in the light of the UK's commitment to the elimination of viral hepatitis C by 2030 made at the World Health Organisation in May, what measures they are putting in place to achieve this aim in England, and whether they will reconsider the case for a national improvement framework for hepatitis C.
	tabling member printed	Baroness Randerson
	uin	HL3153
	answer	answer is ministerial correction date of answer 21/11/2016 answer text <p>Several key measures contribute to the United Kingdom’s efforts to achieve the aims of the global strategy, including the national programme of screening of blood donors and blood transfusions for blood-borne viruses to ensure safe supplies. 100% of blood donors are screened with quality assured methods, and national guidance and legislation around infection control in healthcare settings includes a policy for healthcare workers to prevent nosocomial transmission of blood-borne viruses. Prevention efforts focus on minimising harm in people who inject drugs through access to opiate substitution therapies and needle syringe exchange programmes, with National Institute for Health and Care Excellence (NICE) guidance <em>Needle and syringe programmes, 2014</em> to support these interventions. NICE guidance <em>Hepatitis B and C testing: people at risk of infection, 2012</em> has also been published to improve uptake of testing for hepatitis C in various settings. Copies of both publications are attached.</p><p> </p><p>While treatment coverage has been historically low, in 2015, approximately 8000 people infected with hepatitis C were estimated to be treated, an increase of around 40% on the previous year which may reflect improved access to and acceptability of treatments, including the new Direct Acting Antivirals.</p><p> </p><p>Public Health England has published hepatitis C metrics for the report <em>Hepatitis C in the UK 2016 report - Working towards its elimination as a major public health threat</em>. A copy of this report is attached.</p> answering member printed Lord Prior of Brampton attachment 1 file name Hepatitis_C_in_the_UK_2016_report.pdf title Hepatitis C in the UK report 2 file name hepatitis-b-and-c-testing-people-at-risk-of-infection.pdf title Testing people at risk of infection 2012 3 file name needle-and-syringe-programmes.pdf title Needle and syringe programmes 2014 question first answered 21/11/2016 15:34:29 answering member 127 label Biography information for Lord Prior of Brampton
	tabling member	4230 label Biography information for Baroness Randerson

529955

	registered interest
	date	29/06/2016
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Shipping: Inspections
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government what guidance they have issued to ensure that HIV clinics also test patients annually for hepatitis C.
	tabling member printed	Baroness Randerson
	uin	HL882
	answer	answer is ministerial correction date of answer 12/07/2016 answer text <p>In February 2014 the British Association for Sexual Health and HIV (BASSH) convened an expert working group, including representation from Public Health England, to formally review evidence and produce <em>Recommendations for testing for sexually transmitted infections (STIs) men who have sex with men (MSM). </em>The recommendations are attached.</p><p> </p><p>The National Institute for Health and Care Excellence has also published <em>Hepatitis B and C testing - people at risk of infection</em>, recommending testing to all services users at increased risk of infection. A copy of the guidance is attached.</p> answering member printed Lord Prior of Brampton attachment 1 file name Hepatitis B and C testing - People at risk of infection.pdf title Hepatitis B and C testing - people at risk 2 file name Recommendations for testing for Sexually Transmitted Infections in men who have sex with men.pdf title Recommendations question first answered 12/07/2016 15:22:11 answering member 127 label Biography information for Lord Prior of Brampton
	tabling member	4230 label Biography information for Baroness Randerson

386476

	registered interest
	date	30/06/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Liver Diseases
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government when Public Health England's programme of work on liver disease will be published.
	tabling member printed	Baroness Randerson
	uin	HL971
	answer	answer is ministerial correction date of answer 09/07/2015 answer text <p>Public Health England’s liver disease framework will be published in autumn 2015.</p><p> </p> answering member printed Lord Prior of Brampton question first answered 09/07/2015 12:59:16 answering member 127 label Biography information for Lord Prior of Brampton
	tabling member	4230 label Biography information for Baroness Randerson

386477

	registered interest
	date	30/06/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Hepatitis: Drugs
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government what steps they are taking to ensure that NHS England provides patients with hepatitis C access to new drugs approved by the National Institute for Health and Care Excellence without delay, and to ensure that NHS England continues to assess new technologies based on cost-effectiveness rather than affordability.
	tabling member printed	Baroness Randerson
	uin	HL972
	answer	answer is ministerial correction date of answer 09/07/2015 answer text <p>Commissioners are legally required to fund drugs and treatments recommended in National Institute for Health and Care Excellence (NICE) technology appraisal guidance.</p><p> </p><p> </p><p> </p><p>In the absence of guidance from NICE, it is for commissioners, including NHS England, to make funding decisions based on the available evidence.</p><p> </p><p> </p><p> </p><p>Commissioners are required to have in place clear and transparent arrangements for local decision making and for considering individual funding requests taking into account patients’ clinical circumstances.</p><p> </p> answering member printed Lord Prior of Brampton question first answered 09/07/2015 12:59:51 answering member 127 label Biography information for Lord Prior of Brampton
	tabling member	4230 label Biography information for Baroness Randerson